ALLARITY THERAPEUTICS INC (ALLR) Stock Analyst Ratings
USA - NASDAQ:ALLR - US0167445008 - Common Stock
1.46 USD
+0.12 (+8.96%)
1.45 USD
-0.01 (-0.68%)
ChartMill assigns a Buy % Consensus number of 83% to ALLR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is 528.77% above the current price.
ALLR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ALLR.
In the previous month the buy percentage consensus was at a similar level.
ALLR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-26 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-07-28 | Ascendiant Capital | Initiate | Buy |
| 2022-08-23 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-05-27 | Ladenburg Thalmann | Initiate | Buy |
ALLARITY THERAPEUTICS INC / ALLR FAQ
What do analysts expect the price target to be for ALLARITY THERAPEUTICS INC (ALLR)?
7 analysts have analysed ALLR and the average price target is 9.18 USD. This implies a price increase of 528.77% is expected in the next year compared to the current price of 1.46.
Can you provide the consensus rating for ALLARITY THERAPEUTICS INC stock?
The consensus rating for ALLARITY THERAPEUTICS INC (ALLR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.